نتایج جستجو برای: criteria reimbursement

تعداد نتایج: 265003  

2015
W.A.A. Tjalma

The hormone dependent breast and prostate cancers have in general a very good survival, due to the anti-hormonal treatment. A disadvantage of this treatment is the increased risk of osteoporosis and fractures. It is surprisingly to note that denosumab has the same impact on fracture reduction incidence for both sexes, but with different reimbursement criteria. Furthermore there is only reimburs...

Journal: :European Journal of Cardiovascular Prevention & Rehabilitation 2003

1984
Jonathan E. Conklin John V. Lieberman Cathleen A. Barnes Daniel Z. Louis

The current patient classification schemes used in case-mix reimbursement are not fully sensitive to variations in resource consumption that are associated with differential disease severity. Disease staging is a clinically based measure of severity that uses objective medical criteria to assess the stage of disease progression. Its availability in automated form increases its ease of implement...

Journal: :Acta neurologica Taiwanica 2017
Cheng-Yang Hsieh

lization of intravenous thrombolysis with alteplase was very low in Taiwanese patients with acute ischemic stroke(1). One of the reasons is the strict reimbursement guideline made by the Bureau of National Health Insurance (NHI) in 2004(2). In this issue of the Acta Neurologica Taiwanica, Yu-Hsiang Su and co-authors(3) retrospectively evaluated outcomes of their thrombolysed stroke patients who...

2017
Karolina Badora Aleksandra Caban Cécile Rémuzat Claude Dussart Mondher Toumi

In Poland, two proposed amendments to the reimbursement act are currently in preparation; these are likely to substantially change the pricing and reimbursement landscape for both drugs and medical devices. Proposed changes include: alignment of medical device reimbursement with that of pharmaceuticals; relaxing the strict reimbursement criteria for ultra-orphan drugs; establishment of an addit...

Journal: :Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2015
D A Solaman T Chandler A Wright

& Reimbursement All analyses and interpretations of the data are solely those of the authors and do not refl ect the positions or policies of PHMR Ltd. Contact: Mark Ratcliffe, Managing Director, PHMR Ltd., Berkeley Works, Berkley Grove, London, United Kingdom NW1 8XY Offi ce Tel: +44 (0)2036 955 800. E-mail: [email protected]. • To investigate differences between therapeutic innovation cr...

2008
Anna Bartak Jan JV Busschbach

The Canadian Journal of Psychiatry, Vol 52, No 12, December 2007 803 Objective: Despite scientific evidence of effectiveness, psychotherapy for personality disorders is not yet fully deployed, nor is its reimbursement self-evident. Both clinicians and health care policy-makers increasingly rely on evidence-based medicine and health economics when determining a treatment of choice and reimbursem...

The purposes of our study were to identify a drug entry process, collect, and prioritize criteria for selecting drugs for the list of basic health insurance commitments to prepare an “evidence based reimbursement eligibility plan” in Iran.The 128 noticeable criteria were found when studying the health insurance systems of developed countries. Four parts (involving criteria) formed the first que...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید